GT-EPIC
Live / Registered — Registered (as of 11 Aug 2020)
What this means for you
Registered since 11 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88527127
- Registration number
- 6126051
- Mark type
- Stylized text
- Filed
- 22 Jul 2019
- Published for opposition
- 19 Nov 2019
- Registered
- 11 Aug 2020
- Attorney of record
- Muzamil Huq
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the personalized treatment of cancer and oncological conditions; pharmaceuticals, namely, immunotherapies for the personalized treatment of cancer and oncological conditions; immunotherapy products, namely, pharmaceutical products for the personalized treatment of cancer and oncological conditions
Owner
- Geneos Therapeutics, Inc., Plymouth Meeting, PA, US
- Geneos Therapeutics, Inc., Plymouth Meeting, PA, US
- Geneos Therapeutics, Inc., Plymouth Meeting, PA, US
Prosecution history
- 11 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 03 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jan 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 08 Jul 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jul 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Jun 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jun 2020 — USE AMENDMENT FILED
- 25 Jun 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jun 2020 — TEAS STATEMENT OF USE RECEIVED
- 14 Jan 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2019 — PUBLISHED FOR OPPOSITION